Related Experiment Videos

Haplotype analysis of MEN 2 mutations

E Gardner1, L M Mulligan, C Eng

  • 1Department of Pathology, University of Cambridge, UK.

Human Molecular Genetics
|October 1, 1994
PubMed

Insights

Multiple endocrine neoplasia type 2 (MEN 2) is a genetic cancer syndrome caused by RET gene mutations. A specific RET mutation (cys634-->arg) is linked to parathyroid issues in MEN 2A patients.

Area of Science:

  • Genetics
  • Oncology
  • Endocrinology

Background:

  • Multiple endocrine neoplasia type 2 (MEN 2) is an inherited endocrine cancer syndrome.
  • It is caused by germline mutations in the RET receptor tyrosine kinase gene.
  • MEN 2 affects thyroid C cells, adrenal medulla, parathyroid glands, and enteric ganglia.

Purpose of the Study:

  • To investigate the correlation between a specific RET mutation (cys634-->arg) and parathyroid involvement in MEN 2A.
  • To determine if the correlation is due to the mutation itself or linked alleles.

Main Methods:

  • Haplotype analysis was performed on families with MEN 2A.
  • Genetic linkage analysis was used to examine the inheritance patterns of the RET mutation and parathyroid abnormalities.

Main Results:

  • The cys634-->arg RET mutation is directly correlated with parathyroid involvement in MEN 2A.
  • This correlation is not explained by a linked susceptibility allele but by the mutation itself.
  • New RET mutations leading to MEN 2 occur with notable frequency.

Conclusions:

  • The cys634-->arg RET mutation is a key determinant of parathyroid disease in MEN 2A.
  • Understanding genotype-phenotype correlations is crucial for managing MEN 2.
  • The incidence of new MEN 2 mutations warrants attention in genetic screening and counseling.

Related Concept Videos